Using digital tools to help patients with atrial fibrillation reduce alcohol consumption
Official title: Digital Interventions to Study and Influence the Alcohol-Atrial Fibrillation Connection
Funded at University of California, San Francisco · NIH-10980256 · Data updated 2026-11-12
This study is creating a friendly smartphone app to help people with atrial fibrillation cut down on alcohol, offering personalized tips and support to encourage healthier choices.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | September 5, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $725,580 |
| NIH project number | 2R01AA022222-06A1 |
| Project ID | NIH-10980256 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with atrial fibrillation who also consume alcohol.
✕Less likely to help
Patients who do not have atrial fibrillation or those who do not consume alcohol may not benefit from this research.
What this research studies
This research aims to develop a smartphone application designed to help patients with atrial fibrillation (AF) reduce their alcohol intake. By collaborating with AF patients and experts in behavioral change, the project will create a user-friendly app that provides personalized feedback on the relationship between alcohol consumption and AF episodes. The app will also offer real-time encouragement for abstinence and utilize data from smartwatches to enhance its effectiveness. The goal is to leverage technology to promote healthier behaviors in patients at risk of AF.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of atrial fibrillation episodes in patients who consume alcohol.
How similar studies have gone: Previous research has shown that digital interventions can effectively promote behavior change, particularly in reducing alcohol consumption among patients with similar health conditions.
Where this research is happening
-
University of California, San Francisco
San Francisco, United States Active
Researchers
- Principal investigator: Marcus, Gregory M — University of California, San Francisco
- Study coordinator: Marcus, Gregory M
Related research
Other NIH-funded projects on the same topics.
-
Cardiomyocyte-fibroblast signaling in atrial fibrillation
A researcher at Baylor College of Medicine is studying how signals between heart muscle cells and supportive heart cells influence atrial fibrillation, with the goal of finding new ways to prevent or treat this common heart rhythm problem.
-
Anticoagulation in ICH Survivors with Atrial Fibrillation and Small Vessel Disease
This project looks at how to safely use blood-thinning medicines in people who survived a brain bleed and also have atrial fibrillation and small vessel disease.
-
Lowering heart inflammation to reduce atrial fibrillation risk in people with diabetes
Seeing whether blocking a pro-inflammatory enzyme or boosting the heart's natural inflammation-resolving signals can lower atrial fibrillation risk in people with diabetes.
-
Atrial fibrillation, clots, and stroke: the heart’s JNK2 as a target
This NIH grant explores how a heart protein called JNK2 may drive atrial fibrillation, blood clots, and stroke, and whether it could serve as a biomarker and new treatment approach.
-
A risk score to spot high-risk heart failure patients without atrial fibrillation who may need anticoagulation
A new tool uses patient data and heart MRI markers to identify heart failure patients without atrial fibrillation who might benefit from anticoagulation while minimizing bleeding risk.
-
DECIDE-AF: a shared decision tool in your health portal to help prevent strokes in atrial fibrillation
A patient-friendly tool in your electronic health record helps you and your doctor choose the right way to prevent strokes if you have atrial fibrillation.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.